Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma M Allister

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Canadian Journal of Physiology and Pharmacology|April 26, 2012
MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR miceAlpana Bhattacharjee, Emma M Allister, Michael B Wheeler
Diabetes|July 25, 2013
Response to Comment on: Allister et al. UCP2 regulates the glucagon response to fasting and starvation. Diabetes 2013;62:1623-1633Alexandre B Hardy, Emma M Allister, Michael B Wheeler
Molecular & Cellular Proteomics : MCP|May 2, 2008
The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approachHongfang Lu, Ying Yang, Emma M Allister, et al.
Diabetes|May 28, 2005
Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytesEmma M Allister, Nica M Borradaile, Jane Y Edwards, et al.
Diabetes|November 12, 2009
Molecular and metabolic evidence for mitochondrial defects associated with beta-cell dysfunction in a mouse model of type 2 diabetesHongfang Lu, Vasilij Koshkin, Emma M Allister, et al.
Journal of Biomedical Science|December 14, 2004
Insulin decreases the secretion of apoB-100 from hepatic HepG2 cells but does not decrease the secretion of apoB-48 from intestinal CaCo-2 cellsEmma M Allister, Sebely Pal, Andrew M Thomson, et al.
Journal of Cell Science|February 28, 2013
SDF2L1 interacts with the ER-associated degradation machinery and retards the degradation of mutant proinsulin in pancreatic β-cellsAkansha Tiwari, Irmgard Schuiki, Liling Zhang, et al.
Clinical Biochemistry|June 1, 2005
Quality assessment of microarray experimentsDavid E Carter, John F Robinson, Emma M Allister, et al.
Journal of Lipid Research|July 1, 2008
Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptorEmma M Allister, Erin E Mulvihill, P Hugh R Barrett, et al.
The Journal of Biological Chemistry|October 5, 2012
Glutathionylation state of uncoupling protein-2 and the control of glucose-stimulated insulin secretionRyan J Mailloux, Accalia Fu, Christine Robson-Doucette, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Canadian Journal of Physiology and Pharmacology|April 26, 2012
MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR miceAlpana Bhattacharjee, Emma M Allister, Michael B Wheeler
Diabetes|July 25, 2013
Response to Comment on: Allister et al. UCP2 regulates the glucagon response to fasting and starvation. Diabetes 2013;62:1623-1633Alexandre B Hardy, Emma M Allister, Michael B Wheeler
Molecular & Cellular Proteomics : MCP|May 2, 2008
The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approachHongfang Lu, Ying Yang, Emma M Allister, et al.
Diabetes|May 28, 2005
Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogen-activated protein kinase pathway in hepatocytesEmma M Allister, Nica M Borradaile, Jane Y Edwards, et al.
Diabetes|November 12, 2009
Molecular and metabolic evidence for mitochondrial defects associated with beta-cell dysfunction in a mouse model of type 2 diabetesHongfang Lu, Vasilij Koshkin, Emma M Allister, et al.
Journal of Biomedical Science|December 14, 2004
Insulin decreases the secretion of apoB-100 from hepatic HepG2 cells but does not decrease the secretion of apoB-48 from intestinal CaCo-2 cellsEmma M Allister, Sebely Pal, Andrew M Thomson, et al.
Journal of Cell Science|February 28, 2013
SDF2L1 interacts with the ER-associated degradation machinery and retards the degradation of mutant proinsulin in pancreatic β-cellsAkansha Tiwari, Irmgard Schuiki, Liling Zhang, et al.
Clinical Biochemistry|June 1, 2005
Quality assessment of microarray experimentsDavid E Carter, John F Robinson, Emma M Allister, et al.
Journal of Lipid Research|July 1, 2008
Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptorEmma M Allister, Erin E Mulvihill, P Hugh R Barrett, et al.
The Journal of Biological Chemistry|October 5, 2012
Glutathionylation state of uncoupling protein-2 and the control of glucose-stimulated insulin secretionRyan J Mailloux, Accalia Fu, Christine Robson-Doucette, et al.
Pageof 3